UTHSC’s Professor Robert Williams Part of Global ENIGMA Consortium Effort to Crack Brain’s Genetic Code

UTHSC's Dr. Robert Williams Among Collaborators on Groundbreaking Brain Research Published in Nature

UTHSC’s Dr. Robert Williams Among Collaborators on Groundbreaking Brain Research Published in Nature

Work of global research alliance – ENIGMA — appears in Nature

In the largest collaborative study of the brain to date, researchers from the University of Tennessee Health Science Center (UTHSC) are part of a global consortium of 190 institutions working to identify eight common genetic mutations that appear to age the brain an average of three years. The discovery could lead to targeted therapies and interventions for Alzheimer’s disease, autism and other neurological conditions. [Read more...]

UT Brand Added to Largest Hospital in Methodist Le Bonheur Healthcare System

New signage featuring the UT logo is unveiled.

New signage featuring the UT logo is unveiled at Methodist UT Hospital.

The bright orange UT logo unveiled Wednesday, Feb. 25, on exterior signage at the largest and most comprehensive hospital in the Methodist Le Bonheur Healthcare system is a striking symbol of a successful partnership that started more than a decade ago and continues to grow.

That partnership between the University of Tennessee Health Science Center (UTHSC) and Methodist Le Bonheur Healthcare system supports a multidisciplinary  collaboration among physicians and clinical teams, and brings the most advanced medical care to patients in the Mid-South.

Members of the UT board of trustees, in Memphis for their winter meeting, joined administrators and dignitaries from Methodist and UTHSC for a luncheon and unveiling of the impressive signage at the main entrance of Methodist University Hospital, which is now Methodist UT Hospital.

“Placing the UT initials on the downtown Methodist hospital building and reframing the name as Methodist UT Hospital reflects the convergence of the UTHSC and Methodist missions and visions,” said UTHSC Chancellor Steve Schwab, MD. It is the first time in more than a decade that the UT initials appear on a Memphis hospital.

More than 300 physicians are currently in training in Methodist facilities, and more than 1,865 medical and surgical specialists have been trained in these locations since the partnership began. Methodist UT and Le Bonheur Children’s Hospital, the major facilities in the hospital system, are core teaching hospitals of UTHSC, along with five other core teaching partners across the state – Regional One Health and the VA Medical Center in Memphis, the UT Medical Center in Knoxville, Erlanger Health System in Chattanooga, and the Saint Thomas Health system in Nashville.

Faculty members from UTHSC make up a significant complement of the physicians and clinicians who provide care at Methodist UT Hospital while teaching the next generation of health care professionals in the clinical and hospital setting. The hospital is also home to UT Methodist Physicians, an academic physician practice group created in 2013 as an outgrowth of the partnership between the university and the hospital.

Chancellor Schwab welcomed the guests and praised the collaborative effort, which bolsters recruitment of top-quality physicians, fosters clinical research, and provides venues to train UTHSC students. All of these will boost national rankings for both entities and further their commitments to provide world-class care for all.

From left, Methodist Le Bonheur Healthcare CEO Gary Shorb, UTHSC Chancellor Steve Schwab, MD, and Methodist Le Bonheur Healthcare President and COO Michael Ugwueke share congratulations after the unveiling.

From left, Methodist Le Bonheur Healthcare CEO Gary Shorb, UTHSC Chancellor Steve Schwab, and Methodist Le Bonheur Healthcare President and COO Michael Ugwueke share congratulations after the unveiling.

Methodist Le Bonheur Healthcare CEO Gary Shorb; Methodist Le Bonheur Healthcare President and COO Michael Ugwueke, MPH, DHA, FACHE; and Methodist UT Hospital CEO Jeff Liebman, DDM, MBA, addressed the group before the unveiling, offering statistics that reflect the success of the partnership and its benefits to both entities. In 2014, there were 165 UT-affiliated attending MDs at Methodist UT Hospital, accounting for 7,387 inpatient admissions and 2,360 inpatient surgeries. The intent is to continue to grow those numbers.

Plans are also under way to establish or expand residencies and fellowships in oncology and emergency medicine. Areas of expertise, including transplant medicine, stroke and neurological care, oncology, radiology, and thoracic surgery, have flourished as the partnership has grown.

New signage that includes the UT brand is planned throughout the hospital at a cost of about $600,000.

Dr. Teresa Waters, Chair of the UTHSC Department of Preventive Medicine, Leads Study Finding Medicare Penalties Improve Results for Some Hospital-Acquired Conditions

Dr.  Teresa Waters

Dr. Teresa Waters

Medicare penalties implemented in 2008 have made a difference in reducing certain hospital-acquired complications, according to a paper authored by Teresa M. Waters, PhD, chair of the Department of Preventive Medicine in the College of Medicine at the University of Tennessee Health Science Center (UTHSC). [Read more...]

Prof. Edward Chaum Awarded $999,488 Grant for Ocular Trauma Research

Edward Chaum, MD, PhD

Edward Chaum, MD, PhD

Significant eye injuries are common in the military personnel who served in Iraq and Afghanistan. Edward Chaum, MD, PhD, Plough Professor of Retinal Diseases at the University of Tennessee Health Science Center (UTHSC), has received a grant totaling $999,488 from the U.S. Army Medical Research Acquisition Activity to study the effects of ocular trauma. [Read more...]

West Tennessee Regional Forensic Center Participating in National Effort to Learn More About Sudden Death in the Young

The West Tennessee Regional Forensic Center (WTRFC), which is managed by the University of Tennessee Health Science Center (UTHSC), is one of four Tennessee locations participating in the new Sudden Death in the Young (SDY) Case Registry, a national data collection project to learn more about the reasons for sudden and unexplained deaths of those under the age of 20. [Read more...]

UTHSC Prof. Ryan Yates Receives $15,000 Grant Award from UT Research Foundation

Dr. Ryan Yates

Dr. Ryan Yates

Ryan Yates, PharmD, PhD, professor in the Department of Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), is the recipient of a $15,000 award from the University of Tennessee Research Foundation. The award will support a project titled, “Pre-clinical ADMET of JP-153: A Treatment for Retinal Neovascularization.”

Diabetic retinopathy and age-related macular degeneration (AMD) are the leading causes of blindness. While one affects primarily working-age adults and the other aging adults, both contribute to the growth of abnormal blood vessels in the retina, causing bleeding and scar formation. [Read more...]

Francine Rogers Appointed Interim Safety Officer for UTHSC

Francine Rogers

Francine Rogers

Francine Rogers has been named the interim safety officer for the University of Tennessee Health Science Center (UTHSC).

Originally from Massachusetts, Rogers has been employed at UTHSC as the institutional biosafety officer since 2006. She has directed the laboratory safety program since 2009. In addition to these duties, Rogers will have responsibility for ensuring safety compliance and protocol for the entire Memphis campus. The position will report directly to Ken Brown, JD, MPA, PhD, FACHE, executive vice chancellor and chief operations officer for UTHSC. [Read more...]

UTHSC’s Dr. Gabor Tigyi Draws International Attention for Promising Drug Candidate to Fight Radiation Exposure

Tigyi

Dr. Gabor Tigyi

There currently is no antidote for radiation injury. But Gabor Tigyi, MD, PhD, a professor and chair of the Department of Physiology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), and his team have spent more than 15 years working on one.

Dr. Tigyi’s research team has developed a drug candidate that shows promise for use in treating victims of acute radiation sickness from nuclear disasters like the ones at the Fukushima (Japan, 2011) and Chernobyl (Soviet Union, 1986) nuclear power plants. It may also be useful in treating injuries suffered by cancer patients from radiation therapy. [Read more...]